Study of truck drivers and DME shows vision loss, impact on income

Article

Do you have truck-driver patients? Find out why they’re at higher risk for diabetes and resulting vision and income loss.

Chicago-A new study found that persons in the commercial truck driving industry were at heightened risk for developing diabetes and diabetic macular edema (DME) due to:

  • Limited healthy food choices on the road.

  • Limited opportunities to exercise.

  • Unwillingness to start insulin therapy due to perceptions surrounding regulations on commercial vehicle operation and insulin use.

The study also found that the mean total annualized out-of-pocket costs for diabetes-and DME-related care was $4,743.

Hugh R. Parry, president and CEO of Prevent Blindness America, said: "The economic impact from this study alone should serve as a wake-up call to the public and our public servants that this issue must be addressed today in order to protect our future. We look forward to expanding on this study to demonstrate how imperative it is to continue to fund research and expand programs related to this epidemic disease.”

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.